Good Therapeutics’ Offshoot Bonum Launches with $93 Million in Series A (Updated)
BioSpace
Nov 15, 2022
Media
News Archive
Bonum Therapeutics Announces a $93M Series A Financing to Advance a Novel and Validated Class of Conditionally Active Therapies
“We believe that this technology has broad potential and we are excited to apply it in new areas…”
Healthcare Investor Digitalis Ventures Nets $300 Million Fund
Wall Street Journal
Oct 18, 2022
Media
Roche to pay $250M for Good Therapeutics and its targeted drug technology
Biopharmadive
Sep 7, 2022
Media